EMJ Podcast: Insights For Healthcare Professionals

How does scientific evidence become public policy? In the final episode, Christopher Cogle discusses the challenges of translating healthcare innovation into large-scale policy change. Topics include housing policy and mortality, youth tobacco use, vaping regulation, and how the COVID-19 pandemic reshaped public health decision-making.   Timestamps:   00: 49  –  Public Startup   07:08 - Challenges...

In Part 2, Christopher Cogle examines the long-term realities facing cancer survivors. From vaccine hesitancy and quality-of-life disparities to healthcare access and survivorship policy, this episode explores how systems can better support patients beyond active treatment.   Timestamps:   00:5 0  – Vaccine hesitancy   0 4 : 33  – Q oL  after cancer   0 7 : 3 0 – Policy support    11 : 1 0  –  S u...

In this first deep dive, Christopher Cogle explores the evolving landscape of acute myeloid  leuk a emia  (AML). He discusses the challenge of translating research into real-world outcomes, emerging immunotherapies, precision diagnostics, and how innovations such as the Acute Leukemia Methylome Atlas may reshape AML management in the future.   Timestamps:   00: 55  –  Research Gaps   03:50 – Biolo...

Christopher Cogle joins the EMJ Podcast for a quickfire discussion on oncology, innovation, and public health policy. From  personalised  cancer care and AI in medicine to AML challenges and healthcare reform, he shares concise insights from across clinical medicine and policy leadership.

In the final episode, Sharonne N. Hayes discusses how structural inequities and unconscious bias continue to affect cardiovascular outcomes for women and minority patients. From improving diversity in research to leveraging social media responsibly, this episode explores what the future of equitable cardiovascular care could look like. Timestamps: 0:58 – Health equity 4:02 – Improving representati...

In Part 2, Sharonne N. Hayes explores spontaneous coronary artery dissection (SCAD) and how it challenges traditional assumptions about heart attacks. Learn how SCAD differs from atherosclerotic disease, what recent research has uncovered, and how clinicians can navigate complex management decisions. Timestamps: 1:06 – What is SCAD? 2:47 – Practice-changing insights 6:35 – Hormonal influences 8:20...

  I n this episode of Onc Now, Stephen Chan, Clinical Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong, explores the evolving landscape of hepatobiliary and pancreatic cancers. From advances in translational science and precision therapies to the challenges of neuroendocrine tumour care, Chan reflects on the progress made in oncology and the breakthroughs sti...

This podcast was developed by AMJ in collaboration with GSK and is sponsored by GSK . This information is scientific and non-promotional in nature, and intended for US audiences.   Less than 20% of biologic-eligible patients with GINA Step 5 asthma receive biologic therapy. 1,2 In this AMJ podcast, experts discuss how real-world gaps in initiation, access, and adherence can affect whether patients...

Sharonne N. Hayes joins host Saranya Ravindran to discuss how cardiovascular disease presents differently in women. From pregnancy-related complications and menopause to microvascular disease and gaps in clinician education, this episode explores the importance of sex-specific cardiovascular care. Timestamps: 1:04 – Sex-specific differences 2:43 – Pregnancy and preeclampsia 4:38 – Historic underdi...

In this rapid-fire episode, Sharonne N. Hayes answers key questions on women's cardiovascular health, SCAD, unconscious bias, prevention, and the future of equitable heart care. A concise, expert-led overview of the field.

In the final episode, Bryan Tucker explores the future of kidney stone prevention and treatment. From genetics and microbiome research to wearable hydration technology and AI-driven risk prediction, this episode examines how personalised medicine could transform nephrolithiasis care over the next decade. Timestamps: 01:01 – Future changes in kidney stone care 04:21 – Microbiome and stone risk 05:3...

In Part 2, Bryan Tucker discusses the balance between acute intervention and long-term prevention in kidney stone care. Learn why many patients never receive comprehensive metabolic evaluation, how healthcare systems prioritise procedures over prevention, and what changes are needed to improve recurrence prevention. Timestamps: 01:05 – Intervention and long-term prevention 04:01 – Gaps in follow-u...

This podcast has been funded by an educational grant from Viatris. Systemic lupus erythematosus (SLE) is a complex, heterogeneous disease shaped by dysregulated immune pathways, variable organ involvement, and substantial patient burden. In this educational podcast, Anca Askanase explores how a deeper understanding of SLE immunology can help rheumatologists contextualize disease activity, evolving...

Bryan Tucker joins host Catherine Glass to explore why kidney stone disease is becoming increasingly common worldwide. From dietary and metabolic drivers to male predominance and prevention strategies, this episode examines how nephrolithiasis reflects broader shifts in metabolic health and lifestyle. Timestamps: 01:13 – Increased prevalence 03:19 – Metabolic issues 04:30 – Increased prevalence in...

In this rapid-fire episode, Bryan Tucker answers key questions about kidney stone disease, from common myths and overlooked risk factors to hydration, prevention, and emerging technologies. Perfect for listeners short on time but looking for expert insights into the future of nephrolithiasis care.

In the final episode, Naveed Sattar explores the future of cardiometabolic medicine, from novel therapies and AI-driven risk prediction to integrated care pathways and the next generation of preventative strategies for diabetes and cardiovascular disease.   Timestamps:   0:56 – Novel  i nterventions   2:10 – Digital  h ealth and AI   4:17 – Integrated  c are   5:26 – Future  d irections   7:11 – N...

In Part 2, Naveed Sattar discusses obesity, ectopic fat, and cardiovascular risk. Learn how imaging and biomarkers are improving risk identification, why metabolic dysfunction matters beyond BMI, and how GLP-1 therapies are reshaping obesity and cardiovascular care.   Timestamps:   0:56 – Ectopic  f at   11:44 – Metabolic  d ysfunction   13:42 – GLP-1  r eceptor  a gonists   19:05 – Mechanistic  i...

Naveed Sattar joins host Catherine Glass to explore the complex relationship between diabetes and cardiovascular disease. From hyperglycaemia and inflammation to diabetes onset age and risk prediction, this episode examines the mechanisms and evidence shaping cardiometabolic care today.   Timestamps:   0:55 – Diabetes  to  h eart  d isease   4:35 – Age of  o nset   6:21 – Statins   09:01 – Epidemi...

In this rapid-fire episode, Naveed Sattar answers key questions on diabetes, cardiovascular disease, obesity, prevention, and emerging therapies. From precision medicine and GLP-1 receptor agonists to lifestyle interventions and research advice, this concise episode  provides  expert insight into the future of cardiometabolic medicine.  

In the final episode, the focus turns to prevention. Rachel Buckley examines whether Alzheimer's strategies should be sex-specific, the timing of interventions, and how lifestyle factors like physical activity contribute to brain resilience. The discussion also highlights gaps in research and the need for better integration of women's health data. Timestamps: 00:00:45:13 – Sex-disaggregated data f...

This episode explores how reproductive ageing and biological sex influence Alzheimer's disease risk. Rachel Buckley discusses menopause, hormonal changes, genetic factors such as the X chromosome, and emerging evidence showing differences in tau accumulation between women and men. Timestamps: 00:00:55:03 – Menopause and Alzheimer's disease 00:04:51:11 – X chromosome in Alzheimer's disease 00:08:29...

In this first deep dive, Rachel Buckley joins host Catherine Glass to explore how Alzheimer's disease risk can be detected before symptoms appear. From blood-based biomarkers like p-tau217, to AI-driven models of cognitive resilience, the episode examines how risk, progression, and protection can be better understood and predicted over time. Timestamps: 00:00:57:11 – Phosphorylated tau and amyloid...

In this rapid-fire episode, Rachel Buckley answers key questions on Alzheimer's disease, covering sex differences in risk, early predictors of progression, brain resilience, and the most actionable prevention strategies. A concise overview of the evolving science behind personalised Alzheimer's care.

In the final episode ,   h ost Saranya  and Helen Brough examine the  key gaps in allergy care across prevention, diagnosis, and long-term management, and how these challenges  impact  families in practice. It explores barriers to early peanut introduction, highlights inequalities in allergy care and the populations most affected, and looks at how digital tools, education, and outreach could help...

In P art 2 ,  we explore the role of the skin barrier in food allergy development, from how environmental allergen exposure can drive sensitisation to whether early skincare can help prevent disease. Drawing on studies such as SEAL and recent European eczema guidelines, it also tackles common misconceptions and parental concerns, including topical steroid withdrawal and how best to provide reassur...